In conclusion, CuB treatment had a strong growth inhibitory effect in pancreatic cancer cells by decreasing EGFR levels and downstream signaling of PI3K/Akt/mTOR and STAT3. The gene discussed is EGFR; the disease is pancreatic neoplasm.